URGENT: This Altcoin Opportunity Won’t Wait – Act Now

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

Babak Azad Biography and Net Worth

Insider of GoodRx

Babak Azad has served as our Chief Marketing Officer and SVP, Marketing & Communications since October 2019. Mr. Azad is the Founder of Round 2 Ventures, LLC, a marketing consulting business, focused on marketing activities of various clients, including GoodRx from June 2017 to October 2019. Prior to this, Mr. Azad served as a Senior Vice President of Media and Customer Acquisition for Beachbody, LLC, a developer of health and fitness related products, from February 2007 to April 2015. Mr. Azad holds a B.S. in Mathematics from MIT and an M.B.A. from the Stanford Graduate School of Business.

What is Babak Azad's net worth?: The estimated net worth of Babak Azad is at least $56,500.00 as of September 9th, 2021. Mr. Azad owns 12,500 shares of GoodRx stock worth more than $56,500 as of December 23rd. This net worth evaluation does not reflect any other investments that Mr. Azad may own. Learn More about Babak Azad's net worth.
How do I contact Babak Azad?: The corporate mailing address for Mr. Azad and other GoodRx executives is 233 WILSHIRE BLVD. SUITE 990, SANTA MONICA CA, 90401. GoodRx can also be reached via phone at 855-268-2822 and via email at [email protected]. Learn More on Babak Azad's contact information.
Has Babak Azad been buying or selling shares of GoodRx?: Babak Azad has not been actively trading shares of GoodRx within the last three months. Most recently, Babak Azad sold 12,500 shares of the business's stock in a transaction on Tuesday, November 9th. The shares were sold at an average price of $42.23, for a transaction totalling $527,875.00. Learn More on Babak Azad's trading history.
Who are GoodRx's active insiders?: GoodRx's insider roster includes Babak Azad (Insider), Trevor Bezdek (Co-founder & Chairman), Douglas Hirsch (CEO), Bansi Nagji (Insider), Agnes Rey-Giraud (Director), Andrew Slutsky (Insider), Karsten Voermann (CFO), and Scott Wagner (Insider). Learn More on GoodRx's active insiders.
Are insiders buying or selling shares of GoodRx?: During the last twelve months, insiders at the sold shares 1 times. They sold a total of 10,677 shares worth more than $83,921.22. The most recent insider tranaction occured on September, 3rd when Major Shareholder Equity Vii L.P. Spectrum sold 10,677 shares worth more than $83,921.22. Insiders at GoodRx own 4.2% of the company. Learn More about insider trades at GoodRx.
Information on this page was last updated on 9/3/2024.

Babak Azad Insider Trading History at GoodRx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/9/2021	Sell	12,500	$42.23	$527,875.00
10/11/2021	Sell	7,500	$40.91	$306,825.00
9/9/2021	Sell	12,500	$41.92	$524,000.00	12,500
8/12/2021	Sell	6,250	$33.04	$206,500.00
7/9/2021	Sell	12,500	$32.98	$412,250.00	12,500
7/1/2021	Sell	49,584	$34.92	$1,731,473.28	49,584
6/1/2021	Sell	70,833	$37.10	$2,627,904.30	70,833
5/10/2021	Sell	12,500	$33.02	$412,750.00	12,500
4/9/2021	Sell	12,500	$39.70	$496,250.00	12,500
4/1/2021	Sell	21,250	$39.67	$842,987.50	21,250

Babak Azad Buying and Selling Activity at GoodRx

GoodRx Company Overview

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Today's Range

Now: $4.52

$4.37

$4.53

50 Day Range

MA: $5.33

$4.15

$6.96

2 Week Range

Now: $4.52

$4.09

$9.26

Volume

964,600 shs

Average Volume

1,427,372 shs

Market Capitalization

$1.72 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

>> Register for the Workshop Now